A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa Phillips(St Bartholomew's Hospital), Peter W. Szlosarek(St Bartholomew's Hospital)Pharmacological ReportsApril 3, 202310.1007/s43440-023-00480-6Cited by 5SaveCiteExport RISWatch citationsRelated PapersPromoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis|Cell Death and Disease|2012|151Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms|JTO Clinical and Research Reports|2020|30